Simple HPV swab or blood test may spot returning cervical cancer earlier
NCT ID NCT07493928
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether testing for HPV DNA from a cervical swab or a blood sample can help find cervical cancer that has come back after radiotherapy. Researchers will follow 120 patients for two years after treatment, collecting samples at regular visits. The goal is to see how well these tests detect recurrence compared to standard exams and scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, routine test to catch cervical cancer recurrence earlier after radiotherapy, potentially improving outcomes.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (120 patients) and early, so results may not change practice immediately or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELL FREE DNA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Faculty Hospital in Prague
RECRUITINGPrague, 12800, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could Self-Sampling revolutionize cervical cancer screening?
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- Texting parents could be key to curbing HPV-Related cancers
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Pocket-sized HIV test could bring same-day diagnosis to community clinics